Oxidative Stress and Antioxidant Therapies in Friedreich's Ataxia. [PDF]
Jiménez-Jiménez FJ +5 more
europepmc +1 more source
Microgliopathy as a primary mediator of neuronal death in models of Friedreich's Ataxia. [PDF]
Pernaci C +11 more
europepmc +1 more source
Perspectives on current models of Friedreich's ataxia. [PDF]
Kelekçi S +4 more
europepmc +1 more source
The TRKB Agonist 7,8-dihydroxyflavone Alleviates DNA Damage and Apoptosis in a Neuronal Cell Model of Friedreich's Ataxia. [PDF]
Galán-Cruz J +4 more
europepmc +1 more source
Human pluripotent stem cell models of Friedreich's ataxia: innovations, considerations, and future perspectives. [PDF]
Nguyen HT, Napierala M, Napierala JS.
europepmc +1 more source
Skeletal muscle transcriptomics dissects the pathogenesis of Friedreich's ataxia. [PDF]
Indelicato E +12 more
europepmc +1 more source
Early experience on omaveloxolone in adult patients with Friedreich's ataxia: a real-world observational study. [PDF]
Lima SM +7 more
europepmc +1 more source
Characterizing Population Pharmacokinetics of Vatiquinone in Healthy Volunteers and Patients with Friedreich's Ataxia. [PDF]
Hu Y, Gao L, Lee L, Cherry JJ, Kong R.
europepmc +1 more source
Correction: A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol. [PDF]
Georgiou-Karistianis N +36 more
europepmc +2 more sources
Skeletal muscle proteome analysis underpins multifaceted mitochondrial dysfunction in Friedreich's ataxia. [PDF]
Indelicato E +7 more
europepmc +1 more source

